PHASE I-II TRIAL OF IMATINIB MESYLATE (GLEEVEC; STI571) IN TREATMENT OF RECURRENT OLIGODENDROGLIOMA AND MIXED OLIGOASTROCYTOMA. NORTH CENTRAL CANCER TREATMENT GROUP STUDY N0272 (AL...

di Jaeckle, Kurt A., Anderson, S K., Twohy, Erin L., Dixon, Jesse G., Giannini, Caterina, Jenkins, Robert, Egorin, Merrill J., Sarkaria, Jann N., Brown, Paul D., Flynn, P J., Schwerkoske, John, Buckner, Jan C., Galanis, Eva
Pubblicato in J Neurooncol (2019)

Correction to: Phase I–II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group...

di Jaeckle, Kurt A., Anderson, S. K., Twohy, Erin L., Dixon, Jesse G., Giannini, Caterina, Jenkins, Robert, Egorin, Merrill J., Sarkaria, Jann N., Brown, Paul D., Flynn, P. J., Schwerkoske, John, Buckner, Jan C., Galanis, Evanthia
Pubblicato in J Neurooncol (2019)

A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872

di Galanis, Evanthia, Anderson, S. Keith, Twohy, Erin L., Carrero, Xiomara W., Dixon, Jesse G., Tran, David Dinh, Jeyapalan, Suriya A., Anderson, Daniel M., Kaufmann, Timothy J., Feathers, Ryan W., Giannini, Caterina, Buckner, Jan C., Anastasiadis, Panos Z., Schiff, David
Pubblicato in Cancer (2019)

Stereotactic Radiosurgery with or without Whole Brain Radiotherapy for Limited Brain Metastases: A Secondary Analysis of the NCCTG N0574 (Alliance) Randomized Controlled Trial

di Churilla, Thomas M., Ballman, Karla V., Brown, Paul D., Twohy, Erin L., Jaeckle, Kurt, Farace, Elana, Cerhan, Jane H., Anderson, S. Keith, Carrero, Xiomara W., Garces, Yolanda I., Barker, Fred G., Deming, Richard, Dixon, Jesse G., Burri, Stuart H., Chung, Caroline, Ménard, Cynthia, Stieber, Volker W., Pollock, Bruce E., Galanis, Evanthia, Buckner, Jan C., Asher, Anthony L.
Pubblicato in Int J Radiat Oncol Biol Phys (2017)